Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001209191-23-023336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-05 | 2023-04-03 | PCRX | Brege Laura | Dir | M - OptEx | $29.90 | +7,000 | 17.1K | +69% | +$209.3K |
| D | 2023-04-05 | 2023-04-03 | PCRX | Brege Laura | Dir | S - Sale+OE | $40.72 | -7,000 | 10.1K | -41% | -$285.0K |
| D | 2023-04-05 | 2023-04-03 | PCRX | Brege Laura | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | M | A | 7,000 | $29.90 | 17,147 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-03 | S | D | 7,000 | $40.72 | 10,147 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-03 | M | D | 7,000 | $0.00 | 0 | D | $29.90 · — to 2023-06-12 | 7,000 Common Stock | (F2) The option vested in 12 equal monthly installments, provided that the reporting person remained in continuous service with the issuer through each vesting date, and became fully exercisable on June 12, 2014. |